Variant report

Variant	rs689390
Chromosome Location	chr18:11951640-11951641
allele	C/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type
1	chr18:11951098..11953868-chr18:11983215..11985135,2	K562	blood:
2	chr18:11944456..11952400-chr18:11978684..11982486,15	K562	blood:
3	chr18:11945775..11953098-chr18:11977697..11982837,16	K562	blood:
4	chr18:11947580..11949116-chr18:11949691..11952333,2	K562	blood:
5	chr18:11950713..11953292-chr18:11962814..11965398,2	K562	blood:

Variant related genes	Relation type
ENSG00000141401	Chromatin interaction

Extended variants
information (count: 46 )
Associated
traits (count: 1 )

rSNPs within LD-proxies of this variant (count:36)

rs_ID	r²[population]
rs12967365	0.87[AMR][1000 genomes];0.89[EUR][1000 genomes];0.88[ASN][1000 genomes]
rs1662611	0.87[AMR][1000 genomes];0.89[EUR][1000 genomes];0.82[ASN][1000 genomes]
rs16976851	0.86[JPT][hapmap]
rs1787988	0.89[CHB][hapmap];0.92[AMR][1000 genomes];0.90[EUR][1000 genomes];0.88[ASN][1000 genomes]
rs2083810	0.89[AMR][1000 genomes];0.98[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs4239302	0.88[AMR][1000 genomes];0.92[EUR][1000 genomes];0.91[ASN][1000 genomes]
rs4797597	0.86[EUR][1000 genomes];0.83[ASN][1000 genomes]
rs4797603	0.98[AMR][1000 genomes];0.98[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs581799	0.83[CHB][hapmap];0.90[JPT][hapmap];1.00[YRI][hapmap];1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs584669	0.96[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs585176	0.89[CHB][hapmap];0.90[JPT][hapmap];0.90[AMR][1000 genomes];0.98[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs593984	0.95[AMR][1000 genomes];0.92[EUR][1000 genomes]
rs600405	0.90[AMR][1000 genomes];0.99[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs622863	0.84[CHB][hapmap];0.95[JPT][hapmap]
rs630068	0.89[CHB][hapmap];0.90[JPT][hapmap];0.90[AMR][1000 genomes];0.99[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs634311	1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs644270	0.84[AFR][1000 genomes];0.98[AMR][1000 genomes];0.93[EUR][1000 genomes];0.92[ASN][1000 genomes]
rs648676	0.85[CHB][hapmap];0.95[JPT][hapmap]
rs649039	0.84[CHB][hapmap];0.95[JPT][hapmap]
rs6505689	0.83[AMR][1000 genomes];0.87[EUR][1000 genomes]
rs650958	0.90[AMR][1000 genomes];0.98[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs651889	0.90[AMR][1000 genomes];0.98[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs661885	0.85[JPT][hapmap]
rs665149	0.90[AMR][1000 genomes];0.99[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs665169	0.90[AMR][1000 genomes];0.99[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs667733	0.83[EUR][1000 genomes];0.83[ASN][1000 genomes]
rs677254	0.84[CHB][hapmap];0.95[JPT][hapmap]
rs677359	0.85[CHB][hapmap];0.94[JPT][hapmap]
rs682249	0.85[JPT][hapmap]
rs694627	0.80[EUR][1000 genomes]
rs7504853	0.90[AMR][1000 genomes];0.99[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs8098140	0.85[JPT][hapmap]
rs9284395	0.91[AMR][1000 genomes];0.91[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs9946013	0.88[AFR][1000 genomes];0.99[AMR][1000 genomes];0.99[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs9956744	0.90[AMR][1000 genomes];0.99[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs9962216	0.84[EUR][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:10 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	esv3362008	chr18:11647654-11959830	Active TSS Weak transcription Strong transcription Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Genic enhancers Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	42 gene(s)	inside rSNPs	diseases
2	nsv1055453	chr18:11776790-12110135	Weak transcription Active TSS Enhancers Genic enhancers Strong transcription Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	66 gene(s)	inside rSNPs	diseases
3	nsv543654	chr18:11776790-12110135	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer ZNF genes & repeats Strong transcription Genic enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	66 gene(s)	inside rSNPs	diseases
4	esv2758470	chr18:11897023-12076102	Strong transcription Enhancers Active TSS Weak transcription Flanking Active TSS Genic enhancers Bivalent/Poised TSS ZNF genes & repeats Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA	35 gene(s)	inside rSNPs	diseases
5	esv2758713	chr18:11897023-12076102	Flanking Active TSS Active TSS Enhancers Genic enhancers Weak transcription Strong transcription Bivalent/Poised TSS Bivalent Enhancer ZNF genes & repeats Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	35 gene(s)	inside rSNPs	diseases
6	nsv909384	chr18:11907374-12101109	Weak transcription Enhancers Bivalent Enhancer Genic enhancers Flanking Active TSS Bivalent/Poised TSS Active TSS Strong transcription Flanking Bivalent TSS/Enh ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	42 gene(s)	inside rSNPs	diseases
7	nsv1063339	chr18:11909588-11979264	Active TSS Enhancers Weak transcription Flanking Active TSS ZNF genes & repeats Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA	13 gene(s)	inside rSNPs	diseases
8	nsv576495	chr18:11917410-11986557	Flanking Active TSS Enhancers Weak transcription Active TSS ZNF genes & repeats Bivalent Enhancer Genic enhancers Strong transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA	21 gene(s)	inside rSNPs	diseases
9	nsv909385	chr18:11938102-11986557	Weak transcription Active TSS Flanking Active TSS Enhancers Genic enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer ZNF genes & repeats Strong transcription Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	20 gene(s)	inside rSNPs	diseases
10	nsv909386	chr18:11938102-12095950	Weak transcription Strong transcription Enhancers Flanking Active TSS Active TSS Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	34 gene(s)	inside rSNPs	diseases

mRNA abundance (count:1)

SNP	Gene	Cis/trans	Tissue	Source
rs689390	RP11-820I16.1	cis	Esophagus Muscularis	GTEx

Chromatin state (count:55 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr18:11947800-11952400	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
2	chr18:11947800-11954600	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
3	chr18:11947800-11955000	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
4	chr18:11948000-11954400	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
5	chr18:11948200-11951800	Weak transcription	Esophagus	oesophagus
6	chr18:11948200-11952200	Weak transcription	NHEK	skin
7	chr18:11949000-11954000	Weak transcription	HSMMtube	muscle
8	chr18:11949200-11954200	Weak transcription	NHDF-Ad	bronchial
9	chr18:11949200-11954800	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
10	chr18:11949200-11954800	Weak transcription	Adipose Nuclei	Adipose
11	chr18:11949200-11957000	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
12	chr18:11949400-11954000	Weak transcription	HSMM	muscle
13	chr18:11949400-11954800	Weak transcription	NH-A	brain
14	chr18:11949400-11955000	Weak transcription	NHLF	lung
15	chr18:11949400-11955400	Weak transcription	Fetal Lung	lung
16	chr18:11949800-11954000	Weak transcription	Osteobl	bone
17	chr18:11949800-11954200	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
18	chr18:11950000-11951800	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
19	chr18:11950400-11952200	Enhancers	Pancreas	Pancrea
20	chr18:11950600-11954000	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
21	chr18:11950800-11952000	Enhancers	H1 Cell Line	embryonic stem cell
22	chr18:11950800-11952200	Enhancers	Fetal Muscle Trunk	muscle
23	chr18:11950800-11952400	Enhancers	ES-I3 Cell Line	embryonic stem cell
24	chr18:11950800-11952400	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
25	chr18:11951000-11951800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
26	chr18:11951000-11952200	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
27	chr18:11951000-11952200	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
28	chr18:11951000-11952200	Enhancers	Fetal Muscle Leg	muscle
29	chr18:11951000-11952200	Enhancers	Skeletal Muscle Female	skeletal muscle
30	chr18:11951000-11952400	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
31	chr18:11951000-11956600	Enhancers	Placenta	Placenta
32	chr18:11951400-11952000	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
33	chr18:11951400-11952400	Enhancers	HUES48 Cell Line	embryonic stem cell
34	chr18:11951400-11952400	Enhancers	HUES6 Cell Line	embryonic stem cell
35	chr18:11951400-11952400	Enhancers	iPS-15b Cell Line	embryonic stem cell
36	chr18:11951400-11952400	Enhancers	Hela-S3	cervix
37	chr18:11951600-11951800	Enhancers	Ovary	ovary
38	chr18:11951600-11951800	Flanking Active TSS	K562	blood
39	chr18:11951600-11952000	Enhancers	HUES64 Cell Line	embryonic stem cell
40	chr18:11951600-11952000	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
41	chr18:11951600-11952000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
42	chr18:11951600-11952000	Enhancers	Muscle Satellite Cultured Cells	--
43	chr18:11951600-11952000	Enhancers	Cortex derived primary cultured neurospheres	brain
44	chr18:11951600-11952000	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
45	chr18:11951600-11952000	Enhancers	Fetal Stomach	stomach
46	chr18:11951600-11952200	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
47	chr18:11951600-11952200	Enhancers	iPS-18 Cell Line	embryonic stem cell
48	chr18:11951600-11952200	Enhancers	iPS-20b Cell Line	embryonic stem cell
49	chr18:11951600-11952200	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
50	chr18:11951600-11952200	Enhancers	Psoas Muscle	Psoas

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links